NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Pharmaco Group
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Kyrgyz Pharmaceutical Factory Pharmaco Group Starts Production of New Medicines - The largest producer of medicines in Kyrgyzstan “Pharmaco Group” is extending its production line with six new drugs, which belong both to already existent and new therapeutic groups - Pharmaco.kg
Kyrgyz Pharmaceutical Factory Pharmaco Group Starts Production of New Medicines

 

NewswireToday - /newswire/ - Kyrgyzstan, Bishkek, Kyrgyz Republic, 2009/10/20 - The largest producer of medicines in Kyrgyzstan “Pharmaco Group” is extending its production line with six new drugs, which belong both to already existent and new therapeutic groups - Pharmaco.kg.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Evgenii Svinuhov, Operations Manager of «Pharmaco Group»: “We have started to produce six new medications: prescribed antibiotics Cefepime, Cyprofloxacine and Phozinopril, which has antihypertensive effect, and also drugs, that can be sold in drug store without doctor’s prescription – Loratadin, Glycin and Folacin. From now on, there are 25 medications in production line of Pharmaco Group, which are used in gastroenterology, dermatology, gynecology, urology, rheumatology, cardiology, and pediatrics”.

Domestic pharmaceutical company keeps on developing the list of modern and demanded generics, taking into consideration Kyrgyzstan market needs and strictly following the worked out program of import substitution.

Alexandr Karpov, the General Manager of Pharmaco Group: “The decision to extend range of drugs with antibiotics, medicines, that improves functions of cardiovascular system, drugs against allergies and vitamins, was made by taking into account the demand of Kyrgyz people. Nowadays, we observe the increase in the number of able-bodied citizens, who are susceptible to vascular heart diseases. We have introduced modern and highly effective antihypertensive medication, ACE inhibitor of the third generation – Phozinopril Pharmaco for them. Our factory started to produce antibiotics that are acting on different levels of antimicrobial activity for people suffering from various infections and inflammatory diseases. They are characterized by having wide range of activity, short period of treatment and easy usage”.

The Pharmaco Group Company has also started to develop new directions by adding two other therapeutic groups to its production line – antihistaminic drugs (Loratadin Pharmaco) and vitamins (Glycin and Folacin). Folacin – is water-soluble vitamin B9 that is needed for growth and development of blood circulatory and immune systems. Glycin is a regulator of metabolism. It activates and normalizes processes of protective inhibition in Central Nervous System, decreases psycho-emotional stress and increases mental capacity.

Alexandr Karpov, the General Manager of Pharmaco Group LLC: “We will start the production of new drugs before the end of this year. Within the framework of our marketing strategy, we are planning to replace expensive imported drugs with the drugs of domestic producer in our market. Thus, we will provide maximum accessibility of drugs for patients, because the mission of our company is to make all the best to restore and strengthen health of Kyrgyz people and to improve quality of their lives”.

Pharmaco Group (pharmaco.kg) is the only largest pharmaceutical complex in Kyrgyzstan producing medicines of different anatomy-therapeutic categories. Production line includes brand drugs, which have their own trade names. Pharmaco Group specializes on production of solid forms of drugs, producing 500 million of tablets, 100 million of capsules and 12 million of antibiotic powder a year.
Neman-Farm LLC is the main distributor of Pharmaco Group products. For today, Neman-Farm has the largest drug store network in Kyrgyz Republic.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Pharmaco Group

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Kyrgyz Pharmaceutical Factory Pharmaco Group Starts Production of New Medicines

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Sophya Balakina - Pharmaco.kg 
+996 312 375120 sophya.balakina[.]flexicommunications.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Pharmaco Group securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Pharmaco Group / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Celltrion Pharm Selects TrackWise QMS for Scalability and Data Integrity
Ipsen Adds Another Program into its Pre-clinical R&D Oncology Pipeline through An Exclusive Worldwide Collaboration with Accent Therapeutics
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with its AI Immunology Platforms
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
DSM to Acquire First Choice Ingredients to Accelerate Growth in Food and Beverage
STEMCELL Technologies Launches Human Pluripotent Stem Cell Characterization and Banking Services in Partnership with WiCell
Biocon Selects TrackWise to Enable Enterprise Quality Management Across Global Biopharmaceutical Operations
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services
Ipsen and Exicure Enter into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
Ipsen Strengthens its Pre-clinical Oncology Pipeline with An Exclusive Worldwide-collaboration with BAKX Therapeutics, Inc. for BKX-001
Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe Finds Frost & Sullivan
Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcome
Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson’s Disease
Exelixis and Ipsen Announce Cabozantinib in Combination with An Immune Checkpoint Inhibitor Significantly Improved Progression
Ipsen Opts-in to Join Exelixis with Ongoing Development of Cabometyx® for People Living with A Form of Thyroid Cancer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  Limelon Advertising, Co.





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)